Company Financials

LungLife AI, Inc. Financials

Pound sterling

business LungLife AI, Inc. Company Profile

Main Stock Listing

LSE: LLAI

Market Capitalization None as of None

Market Cap History

Valuations Metrics as of May. 5, 2024

Trailing PE -122.64
Forward PE -2.27
Price to Sales TTM £176.62
Price to Book MRQ £83.87
Enterprise to Revenue 90.10
Enterprise to EBITDA -0.77

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2023-12-31
Profit Margin 100.00%
Operating Margin -11839.13%
Return on Assets TTM -28.69%
Return on Equity TTM -51.42%

Income Statement

Revenue TTM £36,662
Revenue per Share TTM £0.00
Quarterly Revenue Growth 64.30%
Gross Profit TTM £46,000
EBITDA £-4,286,266
Net Income to Common TTM £-4,314,161
Diluted EPS TTM £-0.17
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ £2,253,916
Total Cash per Share MRQ £0.11
Total Debt MRQ £
Total Debt to Equity MRQ 4.37
Current Ratio MRQ 2.28
Book Value per Share MRQ £0.31

Cash Flow

Operating Cash Flow TTM £-4,000,940
Levered Free Cash Flow TTM £-2,438,521

LLAI Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding 30,658,600
Float Shares 14,732,936
Avg 10 Volume 22,525
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 48.71%
% Held by Institutions 42.18%

Stock Price Summary

Beta -0.20
Fifty Two Week Low £19.00
Fifty Two Week High £142.10
Fifty Two Week Change -111.54%
Day 50 MA £31.93
Day 200 MA £64.15

Dividends and Splits

Forward Annual Dividend Rate £
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate £0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date